Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 32: 248-254, 1986;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tait, J. F.
Right arrow Articles by Ashwood, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tait, J. F.
Right arrow Articles by Ashwood, E. R.

Clinical Chemistry, Vol 32, 248-254, Copyright © 1986 by American Association for Clinical Chemistry

Improved fluorescence polarization assay for use in evaluating fetal lung maturity. I. Development of the assay procedure

JF Tait, RW Franklin, JB Simpson and ER Ashwood

We describe a fluorescence polarization assay for use in predicting fetal lung maturity, which is suitable for the TDx Analyzer (an automated fluorescence polarimeter). The assay requires 0.5 mL of amniotic fluid and approximately 30 min, and involves the fluorophore 1- palmitoyl-2(6-[(7-nitro-2, 1, 3-benzoxadiazol-4-yl)amino]caproyl) phosphatidylcholine. Reproducible polarization measurements depend on proper regulation of incubation time and temperature, but variations in the concentrations of fluorescent probe and amniotic fluid have little effect on measured polarization and therefore little effect on assay precision. Working solutions of the fluorescent probe are stable for at least nine months when stored at -20 degrees C and pH 5. Interferences include erythrocytes, serum, bilirubin, meconium, and lidocaine.


The following articles in journals at HighWire Press have cited this article:


Home page
 Obstet GynecolHome page
S. S. Srouji, D. B. Carr, C. M. Gardella, T. Benedetti, and J. F. Tait
The Effect of Common Clinical Contaminants on Amniotic Fluid Fluorescence Polarization Results
Obstet. Gynecol., December 1, 2004; 104(6): 1237 - 1243.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. R. Ashwood
Standards of laboratory practice: evaluation of fetal lung maturity
Clin. Chem., January 1, 1997; 43(1): 211 - 214.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Association for Clinical Chemistry.